Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.

GHR expression in vascular tumors is a function of malignancy and cancer progression. These findings support the hypothesis that GH is involved in a paracrine-autocrine mechanism, acting locally ...

Feb. 4, 2025 — A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block ... Routine Brain MRI Screening in Asymptomatic Late Stage ...

Howard Temin was a UW-Madison scientist who shared the 1975 Nobel Prize for his discovery of “reverse transcriptase,” which described how tumor viruses ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...

RenovoRx (RNXT) highlighted its recent abstract presentation at the 2025 Society of Interventional Oncology Annual Conference in Las Vegas, ...

We value keeping the Device Guide up to date.

RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, highlighted its ...

RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...

Morning Pointe Senior Living announces Fred Hutagaol has been selected as the recipient of the Morning Pointe Scholars Endowment scholarship at Southern Adventist University. “The Morning ... more ...

Bioprinting offers a host of benefits that researchers continue to explore. It utilizes a combination of living cells, bio-inks, and 3D printing methods to create complex structures like organs or ...